2nd Annual Pharmaceutical Law Conference

IIR Conferences are pleased to announce the return of our highly successful Pharmaceutical Law Conference.

Join experts from leading pharmaceutical companies, as well as representatives from the nation's most prestigious law firms in a lively discussion about how you can prepare for the regulatory and legal challenges that lie ahead.

In response to the excellent feedback from last year, NEW for 2009 the conference will feature an official conference networking dinner on Thursday 20th August - free of charge for all speakers and registered delegates. Click here for full dinner details. The dinner will provide you with an excellent opportunity to discuss the day's presentations and further network with fellow conference delegates and speakers.

Leverage experience from key pharmaceutical industry experts including:

• Tara Eaton, Senior Corporate Lawyer - Australia & New Zealand, Merck Sharp & Dohme
• Tim James, Manager - Corporate and Government Affairs, Janssen-Cilag Australia
• Lisa Kurian, Corporate Counsel, Wyeth Australia
• Naomi Pearce, IP Director & Counsel Lawyer & Patent Attorney, Hospira Global Pharma R&D 
• Jeremy Levy, Corporate Counsel Australia and New Zealand, Associate Director Baxter Healthcare Pty Ltd
• Jonathan Barlow, Legal Director - Asia Pacific, Hospira
• Dr Chris Sotiropoulos, Manager - Business Development, Orphan Australia
• Anne Trimmer, Chief Executive Officer, Medical Technology Association of Australia
• Dr Janice Hirshorn, Legal Counsel, Eli Lilly Australia  

In addition, learn from the nation's top pharmaceutical industry lawyers including:

• Carolyn Oddie, Partner, Allens Arthur Robinson
• Odette Gourley, Partner, Corrs Chambers Westgarth
• Kim O'Connell, Partner, Mallesons Stephen Jacques
• Dr Teresa Schafer, Director Pharmaceutical Regulatory Affairs, Clayton Utz
• Greg Williams, Partner, Clayton Utz
• Wayne Condon, Principal, Griffith Hack
• Lisa Taliadoros, Partner, Gilbert & Tobin
• Mark Roberts, Partner, Davies Collinson Cave
• Mark Worsman, Senior Associate, DLA Phillips Fox

The 2nd Annual Pharmaceutical Law Conference will explore the following key themes:

• Competition issues for the pharmaceutical industry
• Intellectual property issues
• Hot topics in patent law 08/09: Global analysis
• Pharma patents - it's not all about maximum scope
• Practical implications of recent patent cases
• MA code and related developments for 2009
• Advertising in the pharmaceutical industry
• PBS Reform and unintended consequences of the legislation
• Review of adverse PBS outcomes
• In-house role in promoting business practice compliance
• Processes for obtaining information prior to commencing proceedings
• Senate gene patent inquiry - downstream implications for genetic testing
• The licensing of new in-license products
• Regulatory approaches to biosimilars/bioequivalents  

Endorsed by

The Generic Medicines industry Association (GMiA) provides a unified voice representing the interests of the generic prescription medicines industry in Australia. The GMiA was established to develop good relationships with all constituencies involved in ensuring the continued delivery of pharmaceutical care to the Australian community and to contribute to the long term sustainability of the Pharmaceutical Benefits Scheme (PBS) through support of the principles of the National Medicines Policy.

Media Partner

 

The complete business and professional journal for pharmacists
Now in its 124th year, the AJP is Australia's largest circulating pharmacy publication and remains the most respected and influential publication within pharmacy, the industry and government.

Online Media Partner